Diagnostic and Biotech

Asia Pacific Human Microbiome Market to 2025 - Regional Analysis and Forecasts by Product (Probiotics, Foods, Prebiotics, Medical Foods, Diagnostic Device, Drugs, and Supplements), Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, and Others), Application (Therapeutics and Diagnostics), and Country

  • THE3206950
  • 155 Pages
  • February 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Asia Pacific human microbiome market is expected to reach US$ 207.81 Mn in 2025 from US$ 41.73 in 2017. The market is estimated to grow with a CAGR of 22.8% from 2018-2025. The growth of the market is driven by the factors such as rising chronic disease due to change in lifestyle and growing interest in human microbiome treatment approach. Whereas, stringent regulatory environment and lack of awareness about human microbiome science is likely to have a negative impact on the growth of the market in the coming years.

Probiotics, prebiotics dietary supplements and foods that contain live microbes have been studied thoroughly to assess their effects on human health. The Gut Health Congress was held in Hong Kong Asia in 2018, the conference explore in detail of diet & personalised nutrition, gastrointestinal microbiome and several case studies with regards to clinical studies, diagnostics studies, treatment methods, biomarker developments, molecular therapy and gastrointestinal diseases. Also, the 5th Microbiome R&D and Business Collaboration Congress was held in Taiwan, Asia in March 2019, the conference focused on recent developments in gut microbiome, skin microbiome, infant, women and oral health, therapeutics, microbiome and diet.

Also, many companies are designing and developing many microbiome therapies. Thus, the increasing focus on human microbiome therapies is the prime factor driving the growth of human microbiome market in the coming years.

Japan is anticipated to lead the adoptions of Human microbiome across the Asia Pacific region through the forecast period. Researchers from Japan are using the outcomes of studies on centenarians in the country to try and produce new products that will replicate the beneficial aspects of their microbiota. The goal of the collaboration is to solve few of the major technological hurdles in advancing stem cell research. Moreover, Cykinso (Tokyo) received the US$ 2.3 million (270 million yen) funds from the Regional Health Care Industry Support Fund, develop and sell Mykinso or a test kit for intestinal flora. The company plans to use the funds for business development purposes, which include using the data collected from the intestinal flora tests to develop a system for offering nutritional guidance. Thus, the investments and the initiatives taken by the government are likely to propel the growth of the market in the forecast period.

Exhibit: Rest Of Asia Pacific Human microbiome Market Revenue and Forecasts to 2027 (US$ Bn)

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

By Product

Probiotics

Foods

Prebiotics

Medical Foods

Diagnostic Device

Drugs

Supplements

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

By Disease

Obesity

Diabetes

Autoimmune Disorders

Cancer

Mental Disorders

Others

ASIA PACIFIC HUMAN MICROBIOME- MARKET SEGMENTATION

By Application

Therapeutics

Diagnostics

By Country

U.S.

Canada

Mexico

Companies Mentioned

Enterome

MicroBiome Therapeutics, LLC

Rebiotix Inc.

Yakult Honsha Co., Ltd.

Osel Inc.

Vedanta Biosciences, Inc.

Metabiomics Corporate

Synthetic Biologics, Inc.

DuPont

BiomX Ltd.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. ASIA PACIFIC HUMAN MICROBIOME MARKET - KEY TAKEAWAYS

PART 3. ASIA PACIFIC HUMAN MICROBIOME MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Asia Pacific Human Microbiome Market - By Product

3.2.2 Asia Pacific Human Microbiome Market - By Disease

3.2.3 Asia Pacific Human Microbiome Market - By Application

3.2.4 Asia Pacific Human Microbiome Market North America

3.3 PEST ANALYSIS

3.3.1 Asia Pacific- PEST Analysis

PART 4. ASIA PACIFIC HUMAN MICROBIOME MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Rising Chronic Disease due to change in lifestyle

4.1.2 Growing interest in Human Microbiome Treatment approach

4.2 KEY MARKET RESTRAINTS

4.2.1 Stringent regulatory environment

4.2.2 Lack of Awareness About Human Microbiome Science

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Growing Initiatives To Raise The Awareness in Emerging Nations

4.4 FUTURE TRENDS

4.4.1 The Human Microbiome Drug Development Is Revolutionizing The Medical Industry

4.5 IMPACT ANALYSIS

PART 5. HUMAN MICROBIOME MARKET - ASIA PACIFIC ANALYSIS

5.1 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING

5.3 PERFORMANCE OF KEY PLAYERS

Enterome

Yakult Honsha Co., Ltd.

5.4 EXPERT OPINIONS

PART 6. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY PRODUCT

6.1 OVERVIEW

6.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

6.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

6.4 FOODS MARKET

6.4.1 Overview

6.4.2 Asia Pacific Foods Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 MEDICAL FOOD MARKET

6.5.1 Overview

6.5.2 Asia Pacific Medical Food Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 PROBIOTICS MARKET

6.6.1 Overview

6.6.2 Asia Pacific Probiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 PREBIOTICS MARKET

6.7.1 Overview

6.7.2 Asia Pacific Prebiotics Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 DRUGS MARKET

6.8.1 Overview

6.8.2 Asia Pacific Drugs Market Revenue and Forecasts to 2025 (US$ Mn)

6.9 DIAGNOSTIC DEVICES MARKET

6.9.1 Overview

6.9.2 Asia Pacific Diagnostic Devices Market Revenue and Forecasts to 2025 (US$ Mn)

6.10 SUPPLEMENTS MARKET

6.10.1 Overview

6.10.2 Asia Pacific Supplements Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY DISEASE

7.1 OVERVIEW

7.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY DISEASE, 2017 & 2025 (%)

7.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

7.4 DIABETES MARKET

7.4.1 Overview

7.4.2 Asia Pacific Diabetes Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CANCER MARKET

7.5.1 Overview

7.5.2 Asia Pacific Cancer Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 AUTOIMMUNE DISORDERS MARKET

7.6.1 Overview

7.6.2 Asia Pacific Autoimmune Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.7 OBESITY MARKET

7.7.1 Overview

7.7.2 Asia Pacific Obesity Market Revenue and Forecasts to 2025 (US$ Mn)

7.8 MENTAL DISORDERS MARKET

7.8.1 Overview

7.8.2 Asia Pacific Mental Disorders Market Revenue and Forecasts to 2025 (US$ Mn)

7.9 OTHERS MARKET

7.9.1 Overview

7.9.2 Asia Pacific Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. ASIA PACIFIC HUMAN MICROBIOME MARKET ANALYSIS - BY APPLICATION

8.1 OVERVIEW

8.2 ASIA PACIFIC HUMAN MICROBIOME MARKET, BY APPLICATION, 2017 & 2025 (%)

8.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

8.4 DIAGNOSTICS MARKET

8.4.1 Overview

8.4.2 Asia Pacific Diagnostics Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 THERAPEUTICS MARKET

8.5.1 Overview

8.5.2 Asia Pacific Therapeutics Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

9.4 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

9.5 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.6 ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 China Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2 China Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.7.3 China Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.7.4 China Human Microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8 JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 Japan Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.8.3 Japan Human Microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.8.4 Japan Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9 INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 India Human Microbiome Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 India Human microbiome Market Revenue And Forecasts to 2025, By Product (US$ Mn)

9.9.3 India Human microbiome Market Revenue And Forecasts to 2025, By Disease (US$ Mn)

9.9.4 India Human microbiome Market Revenue And Forecasts to 2025, By Application (US$ Mn)

PART 10. HUMAN MICROBIOME MARKET -INDUSTRY LANDSCAPE

10.1 OVERVIEW

10.2 GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

10.3 ORGANIC GROWTH STRATEGIES

10.3.1 Overview

10.3.2 Product Launch & Approvals

10.3.3 Expansion

10.3.4 Patent and license

10.4 INORGANIC GROWTH STRATEGIES

10.4.1 Overview

10.4.2 Acquisitions

10.4.3 Partnerships, Collaborations & Agreements

10.4.4 Joint Ventures

PART 11. HUMAN MICROBIOME MARKET-KEY COMPANY PROFILES

11.1 ENTEROME

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Financial Overview

11.1.4 Product Portfolio

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 MICROBIOME THERAPEUTICS, LLC

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Financial Information

11.2.4 Product Portfolio

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 REBIOTIX INC.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Financial Overview

11.3.4 Product Portfolio

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 YAKULT HONSHA CO., LTD.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Financial Overview

11.4.4 Product Portfolio

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 OSEL INC.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Financial Overview

11.5.4 Product Portfolio

11.5.5 Swot Analysis

11.5.6 Key Developments

11.6 VEDANTA BIOSCIENCES, INC.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Financial Information

11.6.4 Product Portfolio

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 METABIOMICS CORPORATE

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Financial Overview

11.7.4 Product Portfolio

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 SYNTHETIC BIOLOGICS, INC.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Financial Information

11.8.4 Product Portfolio

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 DUPONT

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Financial Overview

11.9.4 Product Portfolio

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 BIOMX

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Information

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

PART 12. APPENDIX

12.1 ABOUT THE INSIGHT PARTNERS

12.2 GLOSSARY OF TERMS

12.3 METHODOLOGY

12.3.1 Coverage

12.3.2 Secondary Research

12.3.3 Primary Research

LIST OF TABLES

TABLE 1. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 5. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 6. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 7. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 8. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 9. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 11. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 12. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 13. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY PRODUCT (US$ MN)

TABLE 14. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY DISEASE (US$ MN)

TABLE 15. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 16. RECENT PRODUCT LAUNCHES & APPROVALS IN THE HUMAN MICROBIOME MARKET

TABLE 17. RECENT EXPANSIONS IN THE HUMAN MICROBIOME MARKET

TABLE 18. PATENT AND LICENSE ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 19. RECENT ACQUISITIONS IN THE HUMAN MICROBIOME MARKET

TABLE 20. RECENT PARTNERSHIPS & COLLABORATIONS IN THE HUMAN MICROBIOME MARKET

TABLE 21. JOINT VENTURES INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET

TABLE 22. GLOSSARY OF TERMS, HUMAN MICROBIOME MARKET

LIST OF FIGURES

FIGURE 1. JAPAN HUMAN MICROBIOME MARKET, REVENUE (US$ MN), 2018 & 2025

FIGURE 2. ASIA PACIFIC HUMAN MICROBIOME MARKET BY PRODUCT, MARKET SHARE (%), 2017

FIGURE 3. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, MARKET SHARE (%), 2017

FIGURE 4. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, MARKET SHARE (%), 2017

FIGURE 5. HUMAN MICROBIOME MARKET SEGMENTATION

FIGURE 6. ASIA PACIFIC PEST ANALYSIS

FIGURE 7. HUMAN MICROBIOME MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 8. ASIA PACIFIC HUMAN MICROBIOME MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 9. ASIA PACIFIC HUMAN MICROBIOME MARKET, BY PRODUCT, 2017 & 2025 (%)

FIGURE 10. ASIA PACIFIC FOODS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 11. ASIA PACIFIC MEDICAL FOOD MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. ASIA PACIFIC PROBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. ASIA PACIFIC PREBIOTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. ASIA PACIFIC DRUGS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. ASIA PACIFIC DIAGNOSTIC DEVICES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 16. ASIA PACIFIC SUPPLEMENTS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. ASIA PACIFIC HUMAN MICROBIOME MARKET BY DISEASE, 2017 & 2025 (%)

FIGURE 18. ASIA PACIFIC DIABETES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. ASIA PACIFIC CANCER MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. ASIA PACIFIC AUTOIMMUNE DISEASES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. ASIA PACIFIC OBESITY MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 22. ASIA PACIFIC MENTAL DISORDERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. ASIA PACIFIC OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. ASIA PACIFIC HUMAN MICROBIOME MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 25. ASIA PACIFIC DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 26. ASIA PACIFIC THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE, BY COUNTRY, 2017 (US$ MN)

FIGURE 28. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. ASIA PACIFIC HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 30. CHINA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 31. JAPAN HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 32. INDIA HUMAN MICROBIOME MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 33. GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 34. ORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

FIGURE 35. INORGANIC GROWTH STRATEGIES IN THE HUMAN MICROBIOME MARKET, 2015-2018

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370